<?xml version="1.0" encoding="UTF-8"?>
<p>Two live, attenuated vaccines, TC-83 
 <xref rid="pone.0037242-Berge1" ref-type="bibr">[21]</xref> and V3526 
 <xref rid="pone.0037242-Pratt1" ref-type="bibr">[22]</xref> were developed to prevent disease caused by VEEV, Everglades virus and Mucambo virus 
 <xref rid="pone.0037242-Martin1" ref-type="bibr">[23]</xref>–
 <xref rid="pone.0037242-Phillpotts1" ref-type="bibr">[27]</xref> but both formulations caused unacceptable levels of reactogenicity to allow for general licensure 
 <xref rid="pone.0037242-Martin1" ref-type="bibr">[23]</xref>, 
 <xref rid="pone.0037242-Alevizatos1" ref-type="bibr">[28]</xref>, 
 <xref rid="pone.0037242-Casamassima1" ref-type="bibr">[29]</xref>–
 <xref rid="pone.0037242-Bennett1" ref-type="bibr">[32]</xref>.
</p>
